Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. [electronic resource]
Producer: 20111102Description: 3559-66 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bendamustine Hydrochloride
- Drug Resistance, Neoplasm
- Drug-Related Side Effects and Adverse Reactions
- Female
- Humans
- Intention to Treat Analysis
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Middle Aged
- Neoplasm, Residual
- Nitrogen Mustard Compounds -- administration & dosage
- Prospective Studies
- Recurrence
- Rituximab
- Survival Analysis
- Vidarabine -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.